Viewing nowEsomeprazole Magnesium Trihydrate 40mg (Eprasol Tablet)
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Huons Meditech Co., Ltd.

MFDS item code 201903605 · Approved 2019.05.31 · Insurance code 670402210
Treatment of acid-related disorders (including reflux), prevention of ulcers and rebleeding, and relief of gastrointestinal symptoms caused by anti-inflammatory analgesics
This medication is used to treat gastroesophageal reflux disease and erosive reflux esophagitis, and is also effective as a long-term maintenance therapy to prevent recurrence. It is used in combination with antibiotics for the treatment of duodenal ulcers and peptic ulcers associated with Helicobacter pylori infection. In addition, it helps to treat upper gastrointestinal symptoms and gastric ulcers caused by non-steroidal anti-inflammatory drug use and to prevent ulcers. It is also used in the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent rebleeding of gastric/duodenal ulcers after intravenous injection. This medication is used for the relief of symptoms in gastrointestinal diseases and for the treatment and prevention of diseases.
Swallow this medicine with a liquid such as water. Do not chew or crush it. 1. Adults 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms improve, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for ongoing symptom control in patients at high risk of gastric or duodenal ulcer due to NSAID use. 2) Antibiotic combination therapy for eradication of Helicobacter pylori Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continuous NSAID therapy - Treatment of gastric ulcer associated with NSAID use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with NSAID use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should subsequently be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into 2 doses. 6) Maintenance therapy after initiation of intravenous treatment to prevent rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks after initiation of intravenous treatment to prevent rebleeding from gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Since experience with administration to patients with severe renal impairment is limited, use with caution. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20 mg of this medicine. 6. Elderly patients No dose adjustment is necessary.
2. Adolescents 12 years of age and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms improve, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for ongoing symptom control in patients at high risk of gastric or duodenal ulcer due to NSAID use. 3. Children under 12 years of age There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be used by certain patients. For example, it should not be administered to those with an allergy to this drug or its components, or to those with hypersensitivity to certain antibiotics. Also, individuals with specific heart conditions or nursing women should not use this medication. Caution is required when using this medication as various side effects may occur. Common side effects include headaches, abdominal pain, diarrhea, nausea, and vomiting, while rare but serious symptoms may include blood disorders, allergic reactions, liver dysfunction, and skin rashes. When used for an extended period, regular health checks are necessary, particularly monitoring magnesium levels as there could be a risk of low magnesium levels, so blood tests for monitoring are crucial. Additionally, this medication has many drug interactions, and its effects may vary or side effects may increase based on the drugs taken together, so it is essential to inform a physician or pharmacist about any other medications being taken. Use during pregnancy or breastfeeding should be approached cautiously, and use should generally be avoided unless under special circumstances. In cases of overdose, as there are no specific antidotes, immediate hospital visit is necessary for proper treatment, and this medication is not eliminated by dialysis, so symptomatic treatment is required. This medication should be kept out of reach of children, and transferring it to another container could lead to degradation of quality or accidents, so care must be taken.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reactions, back pain, chest pain, substernal chest pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormalities, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, arthritis exacerbation, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory decrease, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorder, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, asthma exacerbation, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, abnormal olfaction, taste loss, taste disturbance, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infections, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, fractures, rhabdomyolysis, myalgia, weakness, cutaneous lupus erythematosus, systemic lupus erythematosus, symptoms of malignant tumors exacerbation, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The proper storage temperature is room temperature between 1 to 30 degrees Celsius, and it should be avoided in extremely hot or cold places.
Pink rectangular film-coated tablet
28 tablets/PTP [(7 tablets/PTP × 4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Huons Meditech Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.